Stock VSTM VERASTEM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Verastem, Inc.

Equities

VSTM

US92337C2035

Delayed Nasdaq
Other stock markets
 03:46:50 2024-05-23 pm EDT 		5-day change 1st Jan Change
11.62 USD -2.19% Intraday chart for Verastem, Inc. -4.20% +42.75%
May. 09 Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 18 Verastem Names John Hayslip as Chief Medical Officer MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERASTEM, INC. Stock Verastem, Inc.
 301M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. VSTM Stock
  4. Charts Verastem, Inc.
  5. Sector Chart